This document provides information about the composition, characteristics, indications, dosage, and adverse reactions of Repaglinide Tablets.
This document is the official package insert for NovoNorm (Repaglinide Tablets), a medication manufactured by Novo Nordisk for the treatment of Type 2 diabetes in adults. It provides comprehensive information on the drug's composition, indications, and specific usage instructions. This manual is written in Chinese.
| Molecular Weight | 452.6 |
|---|---|
| Available Strengths | 0.5mg, 1.0mg, 2.0mg |
The recommended starting dose is 1mg before meals.
Gemfibrozil is prohibited for concurrent use with Repaglinide.
The maximum recommended single dose is 4mg.